Evidence map›Paper›PMID 22870204›Full record

Trial reportPloS one2012

Adaptive pacing, cognitive behaviour therapy, graded exercise, and specialist medical care for chronic fatigue syndrome: a cost-effectiveness analysis.

Paul McCrone, Michael Sharpe, Trudie Chalder, Martin Knapp, Anthony L Johnson, Kimberley A Goldsmith, Peter D White

RetractedOpen access · goldAbstract readClinical TrialComparative StudyMulticenter Study
In one paragraph

Trial report in PloS one, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It has been retracted, and should not be counted. Cited by 39 papers, 8 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
39citing papers in PubMed, 8 pooled it
2.5field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

39 citing papers in PubMed, 8 syntheses or guidelines pooled it, 84 citations in OpenAlex.

  1. Exercise therapy for chronic fatigue syndrome.The Cochrane database of systematic reviews · 2024
    Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. CBT to reduce healthcare use for medically unexplained symptoms: systematic review and meta-analysis.The British journal of general practice : the journal of the Royal College of General Practitioners · 2019
    Pooled it
  6. Pooled it
  7. Exercise therapy for chronic fatigue syndrome.The Cochrane database of systematic reviews · 2017
    Pooled it
  8. Exercise therapy for chronic fatigue syndrome.The Cochrane database of systematic reviews · 2016
    Pooled it
  9. Trial
  10. Trial
  11. Trial
  12. Trial
  13. Trial
  14. Trial
  15. Trial
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors at 5 institutions in 1 country.

Paul McCroneCentre for the Economics of Mental and Physical Health, Health Service and Population Research Department, Institute of Psychiatry, King's College London, London, United Kingdom. paul.mccrone@kcl.ac.uk
Michael Sharpe
Trudie Chalder
Martin Knapp
Anthony L Johnson
Kimberley A Goldsmith
Peter D White
King's College London · GBLondon School of Economics and Political Science · GBMRC Biostatistics Unit · GBQueen Mary University of London · GBUniversity of Oxford · GB

Funding

Chief Scientist OfficeDepartment of Health DRF-2011-04-061Medical Research Council G0200434
6 · The paper itself

Abstract

backgroundThe PACE trial compared the effectiveness of adding adaptive pacing therapy (APT), cognitive behaviour therapy (CBT), or graded exercise therapy (GET), to specialist medical care (SMC) for patients with chronic fatigue syndrome. This paper reports the relative cost-effectiveness of these treatments in terms of quality adjusted life years (QALYs) and improvements in fatigue and physical function.

methodsResource use was measured and costs calculated. Healthcare and societal costs (healthcare plus lost production and unpaid informal care) were combined with QALYs gained, and changes in fatigue and disability; incremental cost-effectiveness ratios (ICERs) were computed.

resultsSMC patients had significantly lower healthcare costs than those receiving APT, CBT and GET. If society is willing to value a QALY at £30,000 there is a 62.7% likelihood that CBT is the most cost-effective therapy, a 26.8% likelihood that GET is most cost effective, 2.6% that APT is most cost-effective and 7.9% that SMC alone is most cost-effective. Compared to SMC alone, the incremental healthcare cost per QALY was £18,374 for CBT, £23,615 for GET and £55,235 for APT. From a societal perspective CBT has a 59.5% likelihood of being the most cost-effective, GET 34.8%, APT 0.2% and SMC alone 5.5%. CBT and GET dominated SMC, while APT had a cost per QALY of £127,047. ICERs using reductions in fatigue and disability as outcomes largely mirrored these findings.

conclusionsComparing the four treatments using a health care perspective, CBT had the greatest probability of being the most cost-effective followed by GET. APT had a lower probability of being the most cost-effective option than SMC alone. The relative cost-effectiveness was even greater from a societal perspective as additional cost savings due to reduced need for informal care were likely.

Indexed as

AdultCognitive Behavioral TherapyCosts and Cost AnalysisExercise TherapyFatigue Syndrome, ChronicFemaleHumansMaleMiddle AgedUnited Kingdom

Identifiers

PMID22870204
PMCPMC3411573
OpenAlexW2134945464

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.